SCHEMBL4754255

SCHEMBL4754255

O=C(c1ccco1)N1CCN(Cc2ccc3ccccc3c2)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.69
ALDH1A1 P00352 7/20 0.68
KDM4E B2RXH2 5/20 0.68
FABP1 P07148 1/20 0.67
FABP6 P51161 1/20 0.67
KMT2A Q03164 5/20 0.63
MEN1 O00255 4/20 0.63
POLB P06746 2/20 0.63
GLA P06280 1/20 0.63
LMNA P02545 2/20 0.62
TSHR P16473 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
MAPT P10636 1/20 0.62
HPGD P15428 1/20 0.62
ALOX12 P18054 1/20 0.62
HTT P42858 1/20 0.62
NPSR1 Q6W5P4 1/20 0.62
L3MBTL1 Q9Y468 1/20 0.62
NPC1 O15118 2/20 0.62
RAB9A P51151 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13149231 0.85 TP53 (0.82) TP53ALDH1A1KDM4EFABP1FABP6
SCHEMBL3242632 0.81 TP53 (0.78) TP53ALDH1A1KDM4EFABP1FABP6
SCHEMBL13546094 0.81 ALDH1A1 (0.78) TP53ALDH1A1KDM4EFABP1FABP6
SCHEMBL13546093 0.81 FABP1 (1.00) TP53ALDH1A1KDM4EFABP1FABP6
SCHEMBL3602106 0.80 KMT2A (0.71) KMT2AMEN1NPC1
SCHEMBL13546095 0.80 KDM4E (0.94) TP53ALDH1A1KDM4EFABP1FABP6
SCHEMBL29275417 0.80 TP53 (0.76) TP53ALDH1A1KDM4EFABP1FABP6
SCHEMBL7074145 0.78 MC4R (0.69) ALDH1A1KDM4EKMT2AMEN1LMNA
SCHEMBL13150708 0.78 FAAH (0.64) KMT2AMEN1NPC1
SCHEMBL16026437 0.78 ALDH1A1 (0.83) TP53ALDH1A1KDM4EKMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008147864-A2 METHODS OF USING PIPERAZINE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-12-04 WO claimed
WO-2008147864-A2 METHODS OF USING PIPERAZINE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-12-04 WO disclosed